Joshua Prager (doctor)

Prager is a recognized expert who speaks nationally and internationally in the administration of Ketamine for depression, CRPS and other pain problems. In 2016, he was involved in writing guidelines for Ketamine treatment under the aegis of the Reflex Sympathetic Dystrophy Syndrome Association (RSDSA).

In 2005, Prager was elected as president of the North American Neuromodulation Society, and served two consecutive, one-year terms as president until 2007. Until 2012, he served as Director at Large of the International Neuromodulation Society.

In 2005, he organized the first meeting of a coalition of pain organizations and all three manufacturers of spinal cord stimulator systems to collaborate on issues of patient access and reimbursement for neuromodulatory procedures. The same year, Prager joined the Medical Evidence Evaluation Advisory Committee (MEEAC), a group appointed by the Governor of California to develop treatment guidelines for medical care of the injured worker. He continued in the role for six years.

He studied as an undergraduate at Stony Brook University, completed his premedical education, and was a graduate student at Harvard University. Prager graduated from Stanford University with M.D. and attended Stanford Graduate School of Business receiving an M.S. in Management/Health Services Research in 1981.

Joshua P. Prager was born in New York City, the son of Julian Arthur Prager (1914–1981) and Eleanor Vernon Goldsmith (maiden; 1917–2008). Joshua is the son of a New York City police officer, and later, a public school mathematics teacher, and a United Cerebral Palsy shelter workshop supervisor. Prager was educated in the New York City public school system